PaulMRidkerMD

Cardiology • Boston, MA

Eugene Braunwald Professor of Medicine, Brigham and Women's Hospital

Join to view full profile

Dr. Ridker is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Ridker's full profile

Already have an account?

Office
900 Commonwealth Ave East
Brigham And Womens Hospital Preventive Medicine Div
Boston, MA 02215
Phone+1 617-278-0869

Fax+1 617-734-1508

Education & Training

Brigham and Women's HospitalFellowship, Cardiovascular Disease, 1989 - 1992
Brigham and Women's HospitalResidency, Internal Medicine, 1986 - 1989
Harvard Medical SchoolClass of 1986

Certifications & Licensure

MA State Medical License 1988 - 2025
American Board of Internal Medicine Internal Medicine

Awards, Honors, & Recognition

America's Top Doctors Castle Connolly, 2003-2014
Boston Magazine Castle Connolly, 2008-2013
Boston Herald Castle Connolly, 2005
Elected Member The American Society for Clinical Investigation, 1999
Super Doctor SuperDoctors.com
Whos Who in Medicine and Healthcare Marquis Whos Who
Fellow (FACC) American College of Cardiology
Join now to see all

Clinical Trials

Inflammation, Infection, and Future Cardiovascular Risk Start of enrollment: 1998 Sep 01
Completed
Thrombotic, Inflammatory & Gene Markers of CVD in Women Start of enrollment: 1999 Sep 01
Completed
JUPITER - Crestor 20mg Versus Placebo in Prevention of Cardiovascular (CV) Events Start of enrollment: 2003 Feb 01
Terminated
Phase 3
The LANCET Trial: A Trial of Long-acting Insulin Injection to Reduce C-reactive Protein in Patients With Type 2 Diabetes Start of enrollment: 2006 Aug 01
Terminated
Phase 4
Cardiovascular Inflammation Reduction Trial Start of enrollment: 2013 Apr 01
Completed
Phase 3
Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT) Start of enrollment: 2017 Mar 23
Terminated
Phase 3
Join now to see all

Publications & Presentations

PubMed

ApoA-I Infusions and Burden of Ischemic Events After Acute Myocardial Infarction: Insights From the AEGIS-II Trial.
C Michael Gibson, Gerald Chi, Danielle Duffy, M Cecilia Bahit, Harvey White
Journal of the American College of Cardiology. 2024-11-26
1 citations
Whole-genome analysis of plasma fibrinogen reveals population-differentiated genetic regulators with putative liver roles.
Jennifer E Huffman, Jayna Nicholas, Julie Hahn, Adam S Heath, Laura M Raffield
Blood. 2024-11-21
1 citations
Universal screening for hsCRP in patients with atherosclerotic disease: a Major therapeutic opportunity.
Giovanna Liuzzo, Paul M Ridker
European Heart Journal. 2024-11-21

Journal Articles

Association of Lipid, Inflammatory, and Metabolic Biomarkers with Age at Onset for Incident Coronary Heart Disease in Women
Sagar B Dugani, Alawi A Alsheikh-Ali, Paul M Ridker, Samia Mora, JAMA Cardiology
Targeting Interleukin-1 and Interleukin-6
Paul Ridker, MD, JACC: Cardiovascular Imaging
Inflammation, Immunity, and Infection in Atherothrombosis
Paul M Ridker, Valentin Fuster, Priscilla Y Hsue, Peter Libby, ScienceDirect
Meta-Analysis of LDL-C Lowering and Mortality
Paul M Ridker, Edward K Duran, JAMA
Relationship of Interleukin-1β Blockade with Incident Gout and Serum Uric Acid Levels: Exploratory Analysis of a Randomized Controlled Trial
Daniel H Solomon, Paul M Ridker, Brendan M Everett, Peter Libby, Annals of Internal Medicine
Modulation of the Interleukin-6 Signalling Pathway and Incidence Rates of Atherosclerotic Events and All-Cause Mortality: Analyses from the Canakinumab Anti-Inflammato...
Paul M Ridker, Brendan M Everett, Christie Ballantyne, Peter Libby, European Heart Journal
Evaluation of the Pooled Cohort Risk Equations for Cardiovascular Risk Prediction in a Multiethnic Cohort from the Women’s Health Initiative
Marian C Limacher, Lisa W Martin, Paul M Ridker, Nancy R Cook, Jennifer G Robinson, Monika M Safford, Nanette K Wenger, Samia Mora, JoAnn E Manson, JAMA
Original Investigation Lipoprotein(A) and Cardiovascular Risk Prediction Among Women
Samia Mora, Paul M Ridker, Nancy R Cook, ScienceDirect
Genome-Wide Meta-Analysis of Macronutrient Intake of 91,114 European Ancestry Participants from the Cohorts for Heart and Aging Research in Genomic Epidemiology Consor...
Paul M Ridker, Nature
Lipoprotein(A) and Cardiovascular Risk Prediction Among Women
Samia Mora, Paul M Ridker, JACC: Cardiovascular Imaging
Effect of Interleukin-1β Inhibition with Canakinumab on Incident Lung Cancer in Patients with Atherosclerosis: Exploratory Results from a Randomised, Double-Blind, Pla...
Paul Ridker, MD, The Lancet
Join now to see all

Lectures

Association of Migraine with Aura and Other Risk Factors with Incident Cardiovascular Disease in Women
Harvard Medical School, Boston, Massachusetts - 10/18/2012
Braunwald Keynote: 100 Years from CRP to Anti-Cytokine Therapy for Atherosclerosis
2019 ACC Scientific Session & Expo, New Orleans - 3/18/2019
Inflammation as a Target of Therapy.
2019 ACC Scientific Session & Expo, New Orleans - 3/17/2019
Clinician’s Guide to Reducing Inflammation to Reduce Atherothrombotic Risk
American College of Cardiology, 58th Annual Scientific Session & Expo, Orlando, Florida, USA
Should Aspirin Be Used for Primary Prevention in the Post-Statin Era?
58th Annual Scientific Session & Expo, Orlando, Florida, USA
Join now to see all

Authored Content

Association of Migraine with Aura and Other Risk Factors with Incident Cardiovascular Disease in WomenJune 2020
Association of Migraine with Aura and Other Risk Factors with Incident Cardiovascular Disease in WomenJune 2020
Association of Migraine with Aura and Other Risk Factors with Incident Cardiovascular Disease in WomenJune 2020
Inhibition of Interleukin-1β by Canakinumab and Cardiovascular Outcomes in Patients with Chronic Kidney DiseaseMay 2018
Join now to see all

Press Mentions

Common Sense Health: Inflammation Markers Tools to Assess Cardiac RiskNovember 21st, 2024
Inflammaging Is Chronic, Stealthy and Can Be a Serious Threat to Your HealthOctober 8th, 2024
Blood Test Predicts 30-Year Cardiovascular Disease Risks for WomenSeptember 20th, 2024
Join now to see all

Grant Support

Cardiovascular Inflammation Reduction Trial (CIRT)National Heart, Lung, And Blood Institute2011–2012
Training Program In The Epidemiology Of CVDNational Heart, Lung, And Blood Institute2005–2011
Training Program Epidemiology Of Cardiovascular DiseaseNational Heart, Lung, And Blood Institute2000–2004
Thrombotic, Inflammatory &Gene Markers Of CVD In WomenNational Heart, Lung, And Blood Institute1999–2002
Secondary Prevention Trial Of Venous ThrombosisNational Heart, Lung, And Blood Institute1998–2002
Inflammation, Infection And Future Cardiovascular RiskNational Heart, Lung, And Blood Institute1998–2000
Epidemiology Of Cardiovascular DiseaseNational Heart, Lung, And Blood Institute1999